Clinical Trial Management Services
From first patient in to last patient out, Precision for Medicine delivers seamless clinical trial management that accelerates timelines and ensures quality. Our global team, advanced infrastructure, and proprietary technologies guide every step, helping you overcome complexity and achieve your development goals.
Your Trusted Global CRO Partner for End-to-End Clinical Trial Management
Award-Winning Clinical Trial Management Services
- Clinical Trial Strategy & Planning
- Accelerated Study Start Up
- End-to-End Clinical Trial Execution
- Seamless Regulatory Submission
-
Global Clinical Strategy Support
Our integrated regulatory, medical, clinical, and statistical expertise guides your program from IND through NDA submission—ensuring compliance, speed, and strategic clarity.
-
Accelerated Regulatory Approvals and Rapid Site Initiation
Streamline regulatory submissions, optimize site selection, and accelerate patient recruitment, ensuring faster start-up and smoother execution for your clinical trial.
-
Seamless Clinical Trial Execution with Expert Oversight
Ensure expert execution with experienced project managers, clinical and medical monitors, and advanced RBQM technology for centralized monitoring. Our strong site relationships keep your trial on track and on time.
-
Clinical Data Excellence for Faster Regulatory Submissions
Deliver accurate, submission-ready data with expert biostatistics, streamlined data management, and comprehensive biometrics support, enabling faster database lock and ensuring regulatory compliance.
How We Deliver Success
Integrating regulatory expertise, global development strategy, and operational excellence ensure seamless trial execution and expedited regulatory submissions. All of this is powered by a robust quality and technology platform that enables real-time risk mitigation and proactive quality management, giving you confidence at every stage.
-
Regulatory Expertise
Regulatory Expertise
Integrating regulatory, clinical, and medical expertise to guide your program from IND through NDA. Our strategies are led by ex-FDA experts, ensuring compliance and accelerating approvals.
-
Strategic Planning
Strategic Planning
Global reach with local expertise. We coordinate global and regional hubs, manage country-specific regulatory planning, and optimize site selection for faster, smarter trial start-up. -
Operational Excellence
Operational Excellence
Data-driven clinical execution supported by strong site partnerships. Standardized global processes, centralized monitoring, and real-time dashboards keep your trial on track and on time. -
Governance, Quality & Insight
Governance, Quality & Insight
Multi-tiered governance structures backed by real-time analytics and risk-based monitoring. Continuous improvement ensures quality and mitigates risk throughout your trial.
Advancing Outcomes at Every Stage
-
Discover Early Phase Excellence
Early Phase Excellence
ExploreExpert trial design and biomarker strategies to optimize early-phase studies. Navigate regulatory pathways and accelerate start-up for faster insights and smarter decisions.
-
Discover Late Phase Success
Late Phase Success
ExploreProven global capabilities to manage large-scale trials with precision. Our integrated approach ensures compliance, quality, and efficiency, driving success from pivotal studies to submission.
Next-Gen Technologies and Data Infrastructure That Accelerate Trial Insights
Industry-leading platforms like Veeva and proprietary solutions such as Cliniscope and Metavate enable data-driven trial execution and improve efficiencies at every stage of development. Our advanced technology ecosystem transforms complexity into actionable insights, empowering smarter decisions and faster progress.
Global Clinical Trial Management Case Studies
-
Read Case Study
Case Study - ONCOLOGY
Conducting Autologous Cell Therapy Research Across Continents
This Phase 1–2 autologous cell therapy study spanned sites across the U.S. and Europe, each operating under distinct regulatory frameworks.
Engaged to oversee trial execution, discover how Precision for Medicine coordinated complex cross-border logistics and site readiness, achieving zero sample or IP loss throughout the program.Read Case Study-
3continents
-
0sample loss
-
-
Read Case Study
Case Study - ONCOLOGY
Phase 3 Prostate Cancer Case Study: Radiopharm Imaging at Scale
This Phase 3 PSMA-targeted imaging trial in prostate cancer, ran across the U.S. and Canada, required on-time administration of a short-lived radiopharmaceutical within hours of delivery. Read how this study scaled while maintaining dose-on-time compliance, zero site shutdowns, and robust imaging data quality.
Read Case Study-
380+participants
-
0Data quality issues
-
Award-winning clinical trial management services
Precision for Medicine’s recognition in the 2024 CRO Leadership Awards across every category reflects more than excellence—it underscores our commitment to advancing your clinical trials. Our award-winning expertise delivers not only superior trial management but also a shared mission to bring transformative therapies to patients worldwide.
See how consistent industry recognition demonstrates our dedication to quality, innovation, and success in clinical trial management.
-
Our partnership with Precision is a true textbook definition of a great collaboration between a sponsor and a CRO.
— Senior Director, Midsize Biotech -
I recognize that relations between Sponsors and CRO vendors can be strained and difficult, often a blaming game; this has never been my experience with this group as it truly felt like a partnership.
— Director, Small Biotech -
We have been delighted with the experience level and work product from the entire project team – they feel like an extension of our internal team.
— Director, Midsize Pharma -
At so many levels, the Precision for Medicine team has been fantastic. I am very grateful for how responsive and how collaborative the whole team is. Very grateful for their help.
— Director, Midsize Biotech
Deep experience with debilitating disease and unique modalities
We understand that every development pathway begins and ends with a patient. Supporting our partners in delivering innovative treatments is our purpose. Leverage our proven expertise across complex therapeutic areas and advanced modalities to bring transformative therapies to those who need them most.
Frequently Asked Questions
How many countries can Precision for Medicine support simultaneously?
Precision delivers truly global trial management, supporting studies across North America, Europe, Asia-Pacific, and Latin America through an integrated network of local experts and regulatory specialists.
We routinely manage multi-country, multi-regional oncology and rare-disease trials, ensuring harmonized trial conduct, consistent data quality, and rapid study start-up across all participating regions.
What is the typical timeline for first-patient-in in multi-region trials?
Timelines vary by indication and geography, but Precision focuses on accelerating feasibility, regulatory submissions, and site activation to expedite FPI timelines.
Our global start-up model—supported by predictive feasibility, country-specific regulatory intelligence, and centralized project governance, typically enables FPI within 3–6 months in priority markets.
How do you manage global regulatory submissions and country-specific compliance?
Our regulatory operations team manages end-to-end global submissions, from IND/CTA strategy and dossier preparation to ongoing Health Authority engagement across each region.
We combine local regulatory expertise, global SOPs, and centralized quality oversight to ensure every country meets its specific requirements, reducing delays, preventing rework, and ensuring inspection-readiness throughout the trial.
How do you manage patient recruitment and retention across regions?
Precision uses data-driven enrollment forecasting, site-level analytics, and real-time centralized monitoring to identify risks early and optimize recruitment strategies.
Our teams work closely with investigators to implement country-specific outreach plans, streamline pre-screening, and support protocol adherence — all of which strengthen retention, diversity, and time-to-enrollment.
What is your monitoring model for global trials (remote vs on-site)?
Every trial is different and we tailor the monitoring strategy to align with the needs of each program. Precision also offers a hybrid monitoring model that is built on:
- Centralized monitoring for real-time insight into data quality and patient safety
- Risk-based approaches informed by analytics to focus resources where they matter most
- Flexible remote and on-site visits aligned with regulatory expectations
Can you support decentralised or hybrid trials across multiple regions?
Yes. We design and manage decentralized and hybrid trial models across multiple regions, leveraging remote assessments, digital tools, home-health services, and flexible visit schedules.
Our operational framework ensures regional regulatory compliance, data integration, and consistent patient experience, making complex global DCTs feasible, scalable, and audit-ready.
Read our latest Precision insights
Stay updated with the latest insights in statistical programming and automation through our blog.
has not third author: true, (SizeLimitingPyMap: {main={}, second={}, third={}})
Radiopharmaceutical Clinical Trials: What Sponsors Need to Know About Selecting a CRO
has not third author: true, (SizeLimitingPyMap: {main={}, second={}, third={}})
Specialized capabilities in every stage of clinical development
Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to accelerate speed to market. Precision can customize and converge our capabilities to meet your program's unique needs—driving efficiency, agility, and success from start to finish.
-
Discover Explore
Global CRO Services
ExploreA recognized leader in oncology and rare diseases with rich experience in complex trials
-
Discover Explore
Laboratory
ServicesExploreExperts in translational and biomarker sciences with worldwide specialty labs and central lab services that are enabling breakthroughs.
-
Discover BiospecimensBiospecimens
-
Discover Diagnostics & CDxDiagnostics & CDx
-
Discover Data IntelligenceData Intelligence
-
Discover CommercializationCommercialization